about
Neurodevelopment in schizophrenia: the role of the wnt pathways.The wnt pathway in mood disordersChanges in BDNF serum levels in patients with major depression disorder (MDD) after 6 months treatment with sertraline, escitalopram, or venlafaxine.Low-dose acetazolamide in the treatment of premenstrual dysphoric disorder: a case series.The role of memantine in the treatment of psychiatric disorders other than the dementias: a review of current preclinical and clinical evidence.Increased serum Dickkopf-1 levels in drug-abusing psychotic patients.Synergism between fluoxetine and the mGlu2/3 receptor agonist, LY379268, in an in vitro model for antidepressant drug-induced neurogenesis.Gender Differences and Psychopathological Features Associated With Addictive Behaviors in Adolescents.Paradoxical sleep deprivation in rats causes a selective reduction in the expression of type-2 metabotropic glutamate receptors in the hippocampus.Group-II metabotropic glutamate receptor ligands as adjunctive drugs in the treatment of depression: a new strategy to shorten the latency of antidepressant medication?Metabotropic glutamate receptors and neuroadaptation to antidepressants: imipramine-induced down-regulation of beta-adrenergic receptors in mice treated with metabotropic glutamate 2/3 receptor ligands.Childhood trauma and resilience in psoriatic patients: A preliminary report.Neurobiological Evidence for the Primacy of Mania Hypothesis
P50
Q30442237-922F10D7-7E89-4A44-AEED-0B4B7D0D4DC0Q36310513-58EE569A-AF21-4DA5-BF5D-AC5E411A7ACCQ37097073-DEB30E6E-5A3D-4942-9618-A6878E646532Q37617314-A2EDB13E-503C-491C-827A-5260DA51B2EBQ38025454-29B603B3-E122-4E7B-8243-7C630EB485F8Q44620574-C8878DEB-99C6-443F-B9B0-A158428C4243Q46848261-DC9073F0-72B1-42C4-A9AD-F658EEED04C2Q47191102-A0E0D24B-FF1D-4051-AB95-3620F5F1C5B7Q47790113-9ECC5EA7-4684-4741-B914-BA70127E4472Q48095462-A73C69DB-2316-46EE-B807-062E666CB4C9Q48871344-9FA5161C-A539-4BEB-AD26-3DB4C6E722E5Q49887276-5DD500CD-631A-42FA-8EAE-403158BE9862Q60445908-3D9FF38E-8E31-40EE-B4B9-42BBD9503C57
P50
description
researcher ORCID ID = 0000-0002-3548-0302
@en
name
Isabella Panaccione
@ast
Isabella Panaccione
@en
Isabella Panaccione
@es
Isabella Panaccione
@nl
type
label
Isabella Panaccione
@ast
Isabella Panaccione
@en
Isabella Panaccione
@es
Isabella Panaccione
@nl
prefLabel
Isabella Panaccione
@ast
Isabella Panaccione
@en
Isabella Panaccione
@es
Isabella Panaccione
@nl
P1153
8563686900
P21
P31
P496
0000-0002-3548-0302